UHS repurchased 2.6M shares at $174 average in first half 2026

Healthcare provider executing share repurchase program with $977.6M remaining authorization as of June 30

What the filing says

Universal Health Services, Inc. (NYSE: UHS) executed share repurchases totaling 2.565 million shares during the first six months of 2026 at an average price of approximately $174 per share, for an aggregate cost of $447.5 million. In the second quarter alone, the company repurchased 1.890 million shares at an average price of approximately $169 per share, costing $320.3 million.

As of June 30, 2026, UHS had $977.6 million in remaining repurchase authorization under its stock repurchase program. The filing indicates that shares may be repurchased "from time to time as conditions allow, on the open market or in negotiated private transactions." The company did not disclose the original authorization amount or authorization date in this earnings release filing.

The repurchases occurred during a period in which UHS reported net income attributable to UHS of $707.1 million (or $11.63 per diluted share) for the first six months of 2026, compared to $669.9 million (or $10.23 per diluted share) in the comparable period of 2025. The company also generated $844.9 million in net cash from operating activities during the six-month period.

Pursuant to this program, during the second quarter of 2026, we have repurchased 1.890 million shares at an aggregate cost of approximately $320.3 million (average price of approximately $169 per share). During the first six months of 2026, we have repurchased 2.565 million shares at an aggregate cost of approximately $447.5 million (average price of approximately $174 per share). — UNIVERSAL HEALTH SERVICES INC 8-K filing  ·  View on SEC EDGAR →

What this means

UHS is actively repurchasing shares under its standing authorization, spending approximately $447.5 million in the first half of 2026. The $977.6 million remaining authorization provides capacity for continued repurchases. The execution price of approximately $174 per share averaged lower in Q2 ($169) than across the six-month period ($174), suggesting share prices may have strengthened in the latter part of H1. With 2.565 million shares repurchased against a weighted average diluted share count of 60.789 million shares in H1 2026, the repurchase program represents a modest but consistent capital allocation tool alongside the company's operational cash generation and debt management activities.

Frequently asked questions

How much did UHS spend on share repurchases in 2026 H1?

UHS repurchased 2.565 million shares at an aggregate cost of approximately $447.5 million during the first six months of 2026, with an average price of approximately $174 per share.

How much authorization remains for future repurchases?

As of June 30, 2026, UHS had approximately $977.6 million in remaining repurchase authorization under its stock repurchase program.

How does UHS execute its share repurchases?

Shares of UHS Class B Common Stock may be repurchased from time to time as conditions allow, on the open market or in negotiated private transactions, giving management flexibility in execution timing and methods.

What was the average price paid per share in Q2 vs. H1 2026?

In Q2 2026, UHS paid approximately $169 per share average, while the H1 2026 average was $174 per share, indicating a modest price increase in later periods.

Does this filing disclose when the current authorization was approved?

No, the filing does not specify the original authorization date, dollar amount, or board approval date for the current repurchase program, only the remaining balance as of June 30, 2026.